. 2017 Apr 18;13(50):300–308. doi: 10.4103/0973-1296.204561
Copyright: © 2017 Pharmacognosy Magazine
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Figure 3.
Representative structures of the major CYP 3A4 inhibitors.